MedTrace Logo

Management of Uterine Leiomyomata and Adenomyosis

NCT05153928 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-12-10

No results posted yet for this study

Summary

1. to determine the role of hysteroscopy and guided biopsy to differentiate between submucosal fibroids and adenomyosis confirmed by histopathological examination
2. to evaluate the efficacy of norethisterone in the treatment of symptomatic adenomyosis and leiomyoma

Conditions

  • Abnormal Uterine Bleeding

Interventions

DRUG

Norethisterone acetate

Norethisterone acetate for 5 months

Sponsors & Collaborators

  • Assiut University

    collaborator OTHER

  • Ahmed Ali Mahmoud

    lead OTHER

Principal Investigators

  • Hisham Mo Taleb, Md · Assiut University

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-10
Primary Completion
2021-11-25
Completion
2021-12-25
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05153928 on ClinicalTrials.gov